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Abstract
Background: Subcapsular hepatic steatosis is a rare atypical pattern of fatty deposition of the liver reported in
patients with diabetic nephropathy receiving peritoneal dialysis with intraperitoneal insulin. To date, there has been
only one pediatric and zero adult cases of subcapsular hepatic steatosis with no history of continuous ambulatory
peritoneal dialysis. We report the first published case of subcapsular hepatic steatosis in an adult diabetic patient
without any history of peritoneal dialysis or evidence of chronic renal disease.
Case presentation: A 46-year-old Caucasian woman with type 2 diabetes mellitus without renal disease presented
to our emergency department with vague abdominal symptoms and vomiting. Her blood glucose levels were
poorly controlled with a range of 400 to 500 mg/dL. She was diagnosed as having subcapsular hepatic steatosis
based on magnetic resonance imaging. Of note, after improved glucose control her subcapsular hepatic steatosis
had nearly resolved.
Conclusions: Subcapsular hepatic steatosis has been exclusively described in patients with continuous ambulatory
peritoneal dialysis and those on intraperitoneal insulin, except for one pediatric case, which was probably due to
incorrect insulin administration. Our case demonstrates that a diagnosis of subcapsular hepatic diagnosis should not
be restricted to those getting continuous ambulatory peritoneal dialysis, but rather expanded to all patients with
uncontrolled blood glucose levels.
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Background
Subcapsular hepatic steatosis (SHS) is an unusual and
rare pattern of fatty deposition of the liver that was first
described by Wanless et al. in 1989 [1]. With the excep-
tion of one pediatric case, all previously published cases
of SHS have been associated with continuous ambula-
tory peritoneal dialysis (CAPD) with intraperitoneal in-
sulin. One theory for the unusual pattern of SHS is that
CAPD exposes the subcapsular hepatocytes to a higher
concentration of insulin than the remainder of the liver.
Subsequently, the insulin blocks the oxidation of free
fatty acids in the hepatocytes and leads to preferential
esterification of triglycerides which then accumulate
within the cell [2].
The most common patterns of hepatic steatosis are
diffuse versus focal depositions adjacent to the falciform
ligament or gallbladder fossa [3]. However, several cases
of atypical distribution have been described in the litera-
ture. In particular, patients with diabetic nephropathy on
CAPD with intraperitoneal insulin have been shown to
have a rare pattern of fat deposition that can be seen on
computed tomography (CT) and magnetic resonance
imaging (MRI). The pattern is often described as discrete
and nodular subcapsular hypoattenuating lesions [2]. Al-
though there has been no clinical adverse effect reported
from this unusual fatty infiltration, it is important to
understand this entity in order to differentiate it from
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other similarly low attenuation lesions such as metastatic
cancer, primary infiltrative neoplasms, hamartomatous
lesions, hematomas, or abscesses [3, 4].
Case presentation
A 46-year-old Caucasian woman with type 2 diabetes
mellitus and bipolar disorder presented to our emer-
gency department with vague abdominal symptoms and
vomiting. Her pertinent history includes left below knee
amputation and right toes amputation for complications
secondary to diabetic neuropathy. At the time of admis-
sion, she was undergoing care for an infected diabetic
ulcer of her right foot. Of note, she did not have a his-
tory of CAPD or a history of renal disease: creatinine
1.23 mg/dL, blood urea nitrogen (BUN) 16 mg/dL. Her
blood glucose levels were poorly controlled via subcuta-
neous insulin injection; she reported a range of 400 to
500 mg/dL at home (due to poor drug compliance). Her
blood glucose levels were decreased to a range of 175 to
378 mg/dL after implementation of a stricter insulin
regimen upon admission. A non-contrast CT scan
showed confluent, bilobar geographic regions of hypoat-
tenuation in a subcapsular distribution throughout her
liver (Fig. 1). A MRI liver protocol was performed for
further evaluation of these indeterminate findings to as-
sess for possible vascular etiology as areas of infarction
could also be possible in this patient. In-phase gradient
echo images demonstrated hyperintense foci in her liver
in a distribution corresponding to the hypoattenuating
regions seen on CT. On the opposed-phase sequence,
there was loss in signal within these areas indicating the
presence of intracellular fat and water (Fig. 2). In
addition, these areas were hypointense to the remaining
hepatic parenchyma on the fat suppression MR se-
quences, confirming presence of fat and thus establish-
ing a diagnosis of SHS. Furthermore, a follow-up CT of
her abdomen and pelvis was performed 3 months later,
which showed near complete resolution of these findings
(Fig. 3). Of note, stricter glucose control had decreased
her average blood glucose level to below 200 mg/dL.
Discussion
Hepatic steatosis is characterized histologically by trigly-
ceride accumulation within the cytoplasm of hepato-
cytes. The two most common causes are associated with
alcohol-related liver disease and insulin resistance/meta-
bolic syndrome. It is very common to diagnose hepatic
steatosis on cross-sectional imaging of the abdomen, as
Fig. 1 Contrast-enhanced computed tomography of the liver in (a) axial and (b) coronal views. Multiple hypodense lesions are noted throughout
the liver in a subcapsular distribution (arrows) as well as perivascular (circle)
Fig. 2 Axial images through the liver confirm subcapsular steatosis as seen on computed tomography in Fig. 1. a Axial T1-weighted in-phase
gradient echo magnetic resonance imaging (repetition time/echo time = 150/4.4) shows areas of hyperintensity in the subcapsular region (arrow).
b Axial T1-weighted opposed-phase gradient echo magnetic resonance imaging (repetition time/echo time = 150/2.2) shows signal loss in the
corresponding subcapsular regions (arrow)
Chowdhary et al. Journal of Medical Case Reports  (2016) 10:370 Page 2 of 4
the prevalence is approximately 15% in the general
population [5]. It is important for the radiologist to
understand both the typical and atypical pattern of fat
accumulation as some may mimic neoplastic disease, in-
flammatory changes, or vascular infarcts. Patients are
generally asymptomatic.
Although the gold standard of diagnosing hepatic stea-
tosis is liver biopsy, the diagnosis of fatty liver can confi-
dently be made with imaging. Diffuse fat deposition in
the liver is the most frequently encountered pattern;
however, there are four other main types: focal depos-
ition and focal sparing, multifocal deposition, perivascu-
lar deposition, and subcapsular deposition [5]. Focal
deposition and focal sparing characteristically occur ad-
jacent to the falciform ligament, in the porta hepatis,
and adjacent to the gallbladder fossa. Multifocal depos-
ition is an uncommon pattern where multiple round or
oval fat foci are scattered throughout the liver and may
mimic true nodules. Perivascular deposition is character-
ized by halos of fat that surround the hepatic vasculature
and create a tram-like or tubular pattern. The last type
is a subcapsular deposition pattern, which has been de-
scribed in the literature with patient on CAPD with in-
sulin added to the dialysate.
Other than one pediatric case in 2012, SHS has been
exclusively described in patients with CAPD [6]. Ours
is the first adult case of SHS without any history of
CAPD or other forms of intraperitoneal insulin ther-
apy. As described by Choh [6], one rationale for the
pathogenesis of this pattern of fatty liver without
CAPD is that it could be secondary to an incorrect
technique of insulin delivery to the anterior abdominal
wall, thereby inadvertently creating intraperitoneal
spillage. Although possible, this is unlikely in our pa-
tient given her body habitus and noncompliance with
medications.
One significant differential of SHS is hepatic infarc-
tions. An important factor that would differentiate this
entity from SHS is vessels coursing through the hypoat-
tenuated areas, making an infarct less likely. Although
this finding was present in our case, our patient
underwent an abdominal MRI scan (Fig. 2) which con-
firmed that the hypoattenuated regions were composed
of fat.
Conclusions
Hepatic steatosis is a common entity in the general
population. The incidence increases in patients with
hyperlipidemia, hypercholesterolemia, obesity, and dia-
betes. It is important to understand the various patterns
of hepatic steatosis, as well as their respective clinical
correlates. Furthermore, it is important to appreciate
that the different patterns of hypoattenuation may
mimic other conditions. Although SHS predominantly
occurs in patients undergoing CAPD with intraperito-
neal insulin, our case demonstrates that the pattern of
SHS should be considered in the differential even in pa-
tients who have not received CAPD.
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Fig. 3 Follow-up scan 3 months after the initial study (Fig. 1) demonstrates resolution of the geographic hypoattenuating areas. The patient
underwent a stricter insulin regimen and education to reduce her average blood glucose levels. a Axial and b coronal views are shown
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